Orient Pharma Co., Ltd. (TPEX:4166)

Market Cap	6.00B
Revenue (ttm)	1.28B
Net Income (ttm)	127.99M
Shares Out	243.04M
EPS (ttm)	0.57
PE Ratio	43.50
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	40,309
Average Volume	148,597
Open	24.35
Previous Close	24.30
Day's Range	24.35 - 24.70
52-Week Range	22.30 - 41.45
Beta	0.04
RSI	50.64
Earnings Date	Nov 28, 2025

About Orient Pharma

Orient Pharma Co., Ltd. engages in the research and development, manufacturing, and sales of drugs in Taiwan and internationally. The company develops anti-psychotics and psychostimulants, as well as drugs for treating Parkinson’s and Alzheimer’s diseases; and products for the treatment of sialorrhea, tuberculosis, and attention deficit hyperactivity disorder. It is also developing drug delivery technologies, such as multi-stages-controlled release technology, trans-dermal patches, oral disintegrating tablets, sustained release technology, and ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2008
• Employees: 173
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4166

Financial Performance

In 2024, Orient Pharma's revenue was 1.22 billion, an increase of 37.41% compared to the previous year's 889.91 million. Earnings were 107.37 million, an increase of 381.76%.